↓ Skip to main content

Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10–17 years of age: Results from a randomised, controlled, double-blind trial

Overview of attention for article published in Vaccine, July 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
1 X user
patent
4 patents

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
58 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10–17 years of age: Results from a randomised, controlled, double-blind trial
Published in
Vaccine, July 2013
DOI 10.1016/j.vaccine.2013.06.081
Pubmed ID
Authors

R R Abu-Elyazeed, T Heineman, G Dubin, M Fourneau, I Leroux-Roels, G Leroux-Roels, J H Richardus, L Ostergaard, J Diez-Domingo, A Poder, P Van Damme, B Romanowski, M Blatter, S A Silfverdal, J Berglund, A Josefsson, A L Cunningham, C E Flodmark, A Tragiannidis, S Dobson, J Olafsson, J Puig-Barbera, M Mendez, S Barton, D Bernstein, J Mares, P Ratner

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 58 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 21%
Other 7 12%
Researcher 6 10%
Student > Bachelor 5 9%
Student > Doctoral Student 4 7%
Other 11 19%
Unknown 13 22%
Readers by discipline Count As %
Medicine and Dentistry 18 31%
Nursing and Health Professions 6 10%
Biochemistry, Genetics and Molecular Biology 4 7%
Psychology 4 7%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Other 8 14%
Unknown 16 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 December 2023.
All research outputs
#5,239,707
of 25,371,288 outputs
Outputs from Vaccine
#4,749
of 16,509 outputs
Outputs of similar age
#41,855
of 206,465 outputs
Outputs of similar age from Vaccine
#36
of 162 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,509 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.7. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 206,465 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 162 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.